Which patients with prostatic carcinoma require a staging bone scan?

British Journal of Urology

Volumn 79, Issue 4, 1997, Pages 611-614

  Kemp, P M ^a   Maguire, G A ^a   Bird, N J ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Neoplasm staging; Prostate specific antigen; Prostatic neoplasms; Radionuclide imaging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE METASTASIS; BONE SCINTISCANNING; CANCER STAGING; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 0031403877     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00121.x     Document Type: Article

References (12)

1. Lentle BC, McGowan DG, Dierich H. Technetium-99M polyphosphate bone scanning in carcinoma of the prostate. Br/Uro/1974;46: 543-8
2. McCarthy P, Ramchandani P, Pollock HM. The prostate. In Stark D, Vanel D eds, Strategies in Oncologic Imaging. London: Martin Dunitz, 1992: 8
3. Osterling JE. Using prostate-specific antigen to eliminate unnecessary diagnostic tests: significant worldwide economic implications. Urology 1995; 46: 26-33
4. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate antigen. Invest Urol 1979; 17: 159
5. Nadji M, Tabei SZ, Castro A et al. Prostatic specific antigen: an immunohistologic marker for prostatic carcinoma. Cancer 1981; 48: 1229
6. Chybowski FM, Larson-Keller JJ, Bergstrall EJ. Osterling JE. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostatic cancer: prostate specific antigen is superior to all other clinical parameters. J Urol 1991; 145: 313-8
7. Osterling E, Martin K, Bergstrall EJ, Löwe C. The use of prostate specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 1993; 269: 57-60
8. Hucharek M, Muscat J. Serum prostate-specific antigen as a predictor of radiographie staging studies in newly diagnosed prostate cancer. Cancer Invest 1995; 13: 31-5
9. Barichello M. Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostate acid phosphatase. Bur Urol 1995; 27: 295-300
10. Rudoni M, Antonini G, Favro M et al. The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer. Eur J Nuc Med 1995; 22: 207-11
11. Osterling JE, Chan DW, Epstein JI et cd. Prostate-specific antigen in the preoperative and postoperative evaluation of localised prostatic cancer treated with radical prostatectomy. / Urol 1988; 139: 766
12. Schaffer DL, Pendergrass HP. Comparison of enzyme, clinical, radiographie and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology 1976; 121: 431-4